title: Tethered vitreous seeds following intravitreal melphalan for retinoblastoma.
authors.affiliation: Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
authors.forename: Jasmine H
authors.initials: JH
authors.lastname: Francis
authors.affiliation: Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill Cornell Medical College, New York, New York.
authors.forename: Brian P
authors.initials: BP
authors.lastname: Marr
authors.affiliation: Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York3Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York.
authors.forename: Scott E
authors.initials: SE
authors.lastname: Brodie
authors.affiliation: Service of Interventional Neuroradiology, Department of Neurosurgery, Weill Cornell Medical College of New York Presbyterian Hospital, New York, New York5Service of Interventional Neuroradiology, Department of Neurology and Radiology, Weill Cornell Medica.
authors.forename: Yves Pierre
authors.initials: YP
authors.lastname: Gobin
authors.affiliation: Ophthalmic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York2Department of Ophthalmology, Weill Cornell Medical College, New York, New York.
authors.forename: David H
authors.initials: DH
authors.lastname: Abramson
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D009366:Neoplasm Seeding; D019572:Retinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D012175:Retinoblastoma / Q000188:drug therapy* / Q000473:pathology; D014822:Vitreous Body / Q000473:pathology*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan